The European Commission has approved SIFI's Akantior as the first therapy anywhere in the world for acanthamoeba keratitis (AK), an ultra-rare parasitic infection that can lead to blindness.

Although Acanthamoeba spp are nearly ubiquitous in our environment, infection in humans is relatively rare. [1] Recently, a spike in rates of contact lens–associated infectious keratitis ...

Acanthamoeba keratitis is an infection caused by an amoeba - a single ... waiting to undergo a second cornea transplant to restore some of her vision. Disturbing pictures show her once light blue eye ...

2013;39(2):158-161. Patient compliance with proper hygiene techniques is critically important for reducing contact lens–related Acanthamoeba spp infection. [2] Perhaps more critical is an ...